Do Urinary Oestrogen Metabolites Predict Breast Cancer?
Author Information
Author(s): EN Meilahn, B De Stavola, DS Allen, I Fentiman, HL Bradlow, DW Sepkovic, LH Kuller
Primary Institution: London School of Hygiene and Tropical Medicine
Hypothesis
Does metabolism favoring the more oestrogenic 16a-OHE1 pathway increase breast cancer risk?
Conclusion
The study suggests that a higher ratio of 2:16a-OHE1 may be linked to a lower risk of breast cancer, although the results were not statistically significant.
Supporting Evidence
- Post-menopausal women who developed breast cancer had a 15% lower 2:16a-OHE1 ratio than matched controls.
- Subjects with metabolite ratios in the highest tertile of 2:16a-OHE1 had about a 30% lower risk than those in the lowest two-thirds.
- The study included a total of 102 incident breast cancer cases and 296 matched control subjects.
Takeaway
This study looked at how certain substances in urine might help predict breast cancer risk in women, showing that some women might be at lower risk based on their urine test results.
Methodology
The study measured urinary oestrogen metabolites in women aged 35 and older from Guernsey, comparing those who developed breast cancer with matched controls.
Limitations
The study lacked sufficient power to detect statistically significant differences due to a small number of cases.
Participant Demographics
Women aged 35 and older from Guernsey, with both premenopausal and postmenopausal participants.
Statistical Information
Confidence Interval
95% CI = 0.29-1.75
Want to read the original?
Access the complete publication on the publisher's website